Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PinkEye Relief is an over-the-counter **homeopathic ophthalmic combination product** marketed by TRP Company for temporary relief of pink eye symptoms such as redness, burning, watering, swelling, grittiness, and overnight crusting. It is supplied as sterile eye drops and sterile eye ointment and contains a fixed combination of highly diluted HPUS-listed ingredients: aconitum napellus root, apis mellifera, argentum nitricum, euphrasia stricta, natrum arsenicicum, and valeriana officinalis. The product is intended for symptomatic relief rather than treatment of infectious conjunctivitis, and its claimed effects are based on homeopathic principles rather than an established pharmacologic mechanism; homeopathic products of this type have not been evaluated by the FDA for safety or efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PinkEye Relief.